The UK IBD Registry

The Inflammatory Bowel Disease (IBD) Registry is the first UK-wide collection of anonymised adult and paediatric IBD data for prospective audit and research. Routine clinical information entered once into an electronic patient record at the point of care, can be used to meet many different needs.

The Registry’s main focus for 2018/19 has been on biologics, and the aim is to develop a near-complete UK Register of IBD patients on biologics by the end of 2017. Being part of the Registry will give IBD teams:

  • Local data to manage their biologics patients and IBD service more effectively
  • The chance to be part of a national audit of the safety and appropriate use of biologics and biosimilars

The IBD Registry Biologics Audit is part of NHS England’s Quality Accounts 2019/20


NHS England Quality Accounts 2019-20 (IBD Audit)

The Inflammatory Bowel Disease (IBD) Audit has been included as part of NHS England’s Quality Accounts 2019/20, and is provided by the IBD Registry. Each Trust should participate in the audit annually and publish a report each June on their NHS Choices website confirming their participation.  The IBD Audit data is part of the main Registry dataset, designed to be as complementary as possible. To assist Trust Audit teams, the IBD Registry provides an additional paid service to help Trusts track and collate their data in preparation for publication.  To find out more about the IBD Audit including the Quality Accounts service, please email: [email protected]


Biologics and Biosimilars

The IBD Registry’s main focus for 2019/20 remains on biologics, with the aim of developing a near-complete UK Register of IBD patients on biologic treatments; increasingly important with the growing number of biologics and biosimilars becoming available. We are capturing and analysing this important data closely so that we can provide IBD teams who are part of the Registry with a picture of the evolving biologics landscape:

  • Local data to manage their biologics patients and IBD service more effectively
  • National picture of biologics use, impact and resulting health outcomes
  • The opportunity to be part of a national audit of the safety and appropriate use of biologics and biosimilars

To find out more, including to join the IBD Registry, please email: [email protected]



IBD Registry and biologics audit data submission deadlines:
11th January 2019 (Closed)
5th April 2019
5th July 2019
4th October 2019


Find out more about:


Latest News

Could you be our new Data Services Manager ?

Our lovely Data Services Manager is off to run a ski chalet for the winter, and so we are looking for the right person to come and join us in this important role.  You will need to be organised and analytical with a customer service mindset - it's all about keeping...

read more

Xmas Holiday Period Cover 2018

We will be closed over the key Xmas and New Year dates (Mon 24th, Tues 25th and Wed 26th December; then Monday 31st December and Tuesday 1st January 2019). For those catching up on data capture in the Xmas quiet period, we are running an essential support service on...

read more

Could your IBD service improve?

Continuing its mission to improve the care that people with IBD receive, the Royal College of Physicians is offering IBD teams an opportunity to participate in a new quality improvement collaborative, consisting of three 1-day learning sessions and supported action...

read more

IBD Registry has a new home

Following the establishment of IBD Registry Limited as an independent not-for-profit company, we have moved offices to: The IBD Registry The Ebbisham Centre 6-7 Derby Square EPSOM KT18 8AG Telephone (unchanged): 0203 393 3969 Contact (unchanged):...

read more

We’re at BSG 2018

If you’re coming to the BSG Annual Meeting in Liverpool next week, do come and say hello to us – we’re at stand B58 in the exhibition.

read more

Audit & Registry – where next?

The UK IBD Registry: introduction

Driving excellence